Inozyme Pharma Inc Ordinary Shares INZY
News
Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference
Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights
Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function
Inozyme Pharma Gets FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency